These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30542273)

  • 1. Changes in Cortical Thickness in Patients With Early Parkinson's Disease at Different Hoehn and Yahr Stages.
    Gao Y; Nie K; Mei M; Guo M; Huang Z; Wang L; Zhao J; Huang B; Zhang Y; Wang L
    Front Hum Neurosci; 2018; 12():469. PubMed ID: 30542273
    [No Abstract]   [Full Text] [Related]  

  • 2. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in spontaneous brain activity in early Parkinson's disease.
    Yang H; Zhou XJ; Zhang MM; Zheng XN; Zhao YL; Wang J
    Neurosci Lett; 2013 Aug; 549():24-8. PubMed ID: 23769726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative study of peripapillary retinal nerve fiber layer thickness and peripapillary vessel density in patients with different stages of Parkinson's disease.
    Yang TY; Zhang TQ; Xie LQ; Zhang Y; Liu SM; Zeng XW; Luo WF; Xu GX
    Int J Ophthalmol; 2023; 16(5):762-769. PubMed ID: 37206174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of Reduced Functional Connectivity and Structural Abnormalities in Parkinson's Disease: An Exploratory Study.
    Guimarães RP; Arci Santos MC; Dagher A; Campos LS; Azevedo P; Piovesana LG; De Campos BM; Larcher K; Zeighami Y; Scarparo Amato-Filho AC; Cendes F; D'Abreu AC
    Front Neurol; 2016; 7():243. PubMed ID: 28133455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Global Synchronizations in Patients With Parkinson's Disease: A Resting-State fMRI Study.
    Li M; Liu Y; Chen H; Hu G; Yu S; Ruan X; Luo Z; Wei X; Xie Y
    Front Aging Neurosci; 2019; 11():139. PubMed ID: 31293411
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of Regional Homogeneity in the Mild and Moderate Stages of Parkinson's Disease.
    Li J; Liao H; Wang T; Zi Y; Zhang L; Wang M; Mao Z; Song C; Zhou F; Shen Q; Cai S; Tan C
    Front Aging Neurosci; 2021; 13():676899. PubMed ID: 34366823
    [No Abstract]   [Full Text] [Related]  

  • 8. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
    Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macular inner plexiform layer thickness as an early diagnostic indicator for Parkinson's disease.
    Wang X; Jiao B; Jia X; Wang Y; Liu H; Zhu X; Hao X; Zhu Y; Xu B; Zhang S; Xu Q; Wang J; Guo J; Yan X; Tang B; Zhao R; Shen L
    NPJ Parkinsons Dis; 2022 May; 8(1):63. PubMed ID: 35614125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry.
    Nürnberger L; Gracien RM; Hok P; Hof SM; Rüb U; Steinmetz H; Hilker R; Klein JC; Deichmann R; Baudrexel S
    Neuroimage Clin; 2017; 13():405-414. PubMed ID: 28116233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of brain structural network properties in patients with rapid eye movement sleep behavior disorder].
    Zhang R; Li Z; Bai Y; Xu P; Zhang J; Zhang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):125-130. PubMed ID: 32376561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.
    Pagonabarraga J; Corcuera-Solano I; Vives-Gilabert Y; Llebaria G; García-Sánchez C; Pascual-Sedano B; Delfino M; Kulisevsky J; Gómez-Ansón B
    PLoS One; 2013; 8(1):e54980. PubMed ID: 23359616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent and divergent intra- and internetwork connectivity in Parkinson's disease with wearing-off.
    Zhai H; Fan W; Xiao Y; Zhu Z; Ding Y; He C; Zhang W; Xu Y; Zhang Y
    Neurol Sci; 2024 Jan; 45(1):155-169. PubMed ID: 37578631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray/White Matter Contrast in Parkinson's Disease.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Front Aging Neurosci; 2018; 10():89. PubMed ID: 29636679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connecting the Dots: Exploring the Relationship between Optical Coherence Tomography and
    Manchanda R; Samanta R; Narayan ML; Kumar M; Tiwari A; Agarwal A; Bahurupi Y; Kumari S; Kumar N
    Ann Indian Acad Neurol; 2024; 27(2):188-195. PubMed ID: 38751926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.
    Giladi N; Nicholas AP; Asgharnejad M; Dohin E; Woltering F; Bauer L; Poewe W
    J Parkinsons Dis; 2016 Oct; 6(4):741-749. PubMed ID: 27567886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The trajectory of disturbed resting-state cerebral function in Parkinson's disease at different Hoehn and Yahr stages.
    Luo C; Guo X; Song W; Chen Q; Yang J; Gong Q; Shang HF
    Hum Brain Mapp; 2015 Aug; 36(8):3104-16. PubMed ID: 25959682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of
    Zhang K; Tang Y; Meng L; Zhu L; Zhou X; Zhao Y; Yan X; Tang B; Guo J
    Front Neurosci; 2019; 13():47. PubMed ID: 30778284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of deep brain stimulation in severe Parkinson's disease utilizing UPDRS III and modified Hoehn and Yahr as a severity scale.
    Kahn L; Mathkour M; Lee SX; Gouveia EE; Hanna JA; Garces J; Scullen T; McCormack E; Riffle J; Glynn R; Houghton D; Lea G; Biro EE; Bui CJ; Sulaiman OA; Smith RD
    Clin Neurol Neurosurg; 2019 Apr; 179():67-73. PubMed ID: 30851616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.